Novavax, Inc. (NVAX): Price and Financial Metrics
Novavax, Inc. (NVAX)
Today's Latest Price: $131.46 USD
4.48 (3.53%)
Updated Jan 25 6:55pm
Add NVAX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
NVAX Stock Summary
- The price/operating cash flow metric for Novavax Inc is higher than 95.78% of stocks in our set with a positive cash flow.
- NVAX's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 98.79% of US stocks.
- Revenue growth over the past 12 months for Novavax Inc comes in at 1,181.88%, a number that bests 99.31% of the US stocks we're tracking.
- If you're looking for stocks that are quantitatively similar to Novavax Inc, a group of peers worth examining would be DRNA, CTMX, NKTR, XNCR, and AGIO.
- Visit NVAX's SEC page to see the company's official filings. To visit the company's web site, go to www.novavax.com.
NVAX Stock Price Chart Interactive Chart >
NVAX Price/Volume Stats
| Current price | $131.46 | 52-week high | $189.40 |
| Prev. close | $126.98 | 52-week low | $6.26 |
| Day low | $125.14 | Volume | 3,010,900 |
| Day high | $131.50 | Avg. volume | 3,209,487 |
| 50-day MA | $116.75 | Dividend yield | N/A |
| 200-day MA | $93.89 | Market Cap | 8.37B |
Novavax, Inc. (NVAX) Company Bio
Novavax, Inc. focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. The company was founded in 1987 and is based in Gaithersburg, Maryland.
Loading social stream, please wait...